Vodori Launches New App on Salesforce AppExchange

Private Equity

Baird Capital portfolio company Vodori announced the launch of its new app on the Salesforce AppExchange. The app allows life sciences organizations to automatically distribute approved, compliant-promotional and medical content within Salesforce Life Sciences Cloud, ensuring faster, more secure delivery to field teams.

"This launch indicates something powerful: life sciences companies now have a choice in how they want to manage regulated content," said Scott Rovegno, CEO of Vodori. "Our mission is to simplify and scale compliant content delivery. By connecting Vodori's review platform to Salesforce, we're helping life sciences companies reduce risk and empower their field teams with the right content at the right time."

Vodori is a leader in cloud-based software for compliant content review and approval in the life sciences industry.

Read the Full Release

Related Links

Hand holding a test tube near a beaker with an abstract image of a keyboard in the background
Our Pharma Services Investment Thesis

Baird Capital is an experienced pharma services investor, with deep knowledge, operating expertise and investment experience in the market.

Learn More
Medical professional holding ipad with icons floating over it.
Baird Capital Invests in Vodori

Baird Capital’s Venture Capital team led a $7.5 million Series A investment in Vodori, a leading cloud software provider whose mission is to empower the commercialization efforts of life science companies.

Keep Reading
Baird Global Private Equity Team
Global Private Equity

With a focus on business-to-business technology and services companies across multiple subsectors, our Global Private Equity platform invests in lower middle-market companies across North America, U.K. and Asia.

Learn More